Work

A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104

Year: 2009

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e3181951eb0

Authors: Ramaswamy Govindan, Xiaofei Wang, Maria Q. Baggstrom, Susan Burdette-Radoux, Lydia Hodgson, Everett E. Vokes, Mark R. Green

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center, Duke University, University of Vermont, University of Chicago, Roper Hospital

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Syracuse University, University of Missouri, University of Minnesota, Georgetown University, National Cancer Institute

Awards: G10814802, G1391839138, G1486637521, G1689128559, G199746015, G257334932, G2647518335, Cancer and Leukemia Group B Statistical Center, G3255944410, G4530377164, Cancer and Leukemia Group B, G6886639697, G877081928, G877907214, G973482110, G979369470

OpenAlex ID: W1973518314

FWCI: 0.63

Cites: 44

Cited by: 12

Related to: 10